CED Digest: 230 Items — March 17, 2026

Alabama Medical Cannabis Sales Gear for Spring 2026 Launch

# Summary Alabama’s medical cannabis program is preparing to begin retail sales in spring 2026, establishing a new patient access pathway that clinicians must prepare to support through recommendations and patient education.

Cannabis compounds CBD and CBG may help reverse fatty liver disease, study finds

# Cannabis Clinician Summary Research indicates CBD and CBG cannabinoids may reverse fatty liver disease pathology, presenting potential therapeutic applications for hepatic conditions in clinical cannabis practice.

From Billion-Dollar Hemp Drinks to FDA Cease-and-Desist Letters: The Cannabis Industry’s …

# Summary Sentence The article examines regulatory enforcement actions against cannabis beverage companies, highlighting compliance challenges clinicians must understand when advising patients about legal product availability and safety standards.

Cannabis Compounds CBD and CBG Show Promise in Reducing Liver Fat and Improving …

# Cannabis Article Summary CBD and CBG cannabinoids demonstrated potential to reduce hepatic steatosis and improve metabolic markers, offering clinicians new therapeutic targets for managing cannabis-related liver health complications.

New Cannabis Group Will Help Ground Policy In Science And Patient Experience As …

I’d be happy to help, but the article summary appears to be incomplete. Could you provide the full summary text so I can accurately describe what the article covers and its relevance to cannabis clinicians?

New Top Cannabis Regulator Sets Priorities In First Board Meeting

# Summary A newly appointed cannabis regulator outlined their priorities at their initial board meeting, establishing the regulatory direction that will shape compliance requirements and clinical practice standards for healthcare providers.

Brazil’s Cannabis Crossroads: New Rules, Old Truths, and the Road Ahead

# Brazil’s Cannabis Regulation: Clinical Relevance This article examines Brazil’s evolving cannabis regulatory framework and its implications for medical practice, helping clinicians navigate changing legal and clinical standards.

2 Greater Cincinnati breweries file lawsuit over Ohio ban on THC beverages – WLWT

# Summary Two Cincinnati breweries are challenging Ohio’s prohibition on THC-infused beverages through litigation, directly affecting the regulatory landscape for cannabis-based products and dosing considerations in clinical practice.

New Ohio law means THC-infused drinks won’t be available on many store shelves – WTVG

# Summary Ohio’s new law restricts THC-infused beverage distribution, limiting retail availability—relevant for clinicians counseling patients on product access, dosing consistency, and legal consumption options.

Lawmakers strike down bill capping THC levels in Oregon’s cannabis edibles – Yahoo

# Summary Oregon lawmakers rejected legislation to limit THC concentrations in cannabis edibles, affecting dosing standardization and patient safety considerations for clinicians prescribing or recommending cannabis products.

Attempt to limit potency of THC in marijuana edibles fails at Oregon Legislature

# Summary Oregon legislators failed to pass limits on THC potency in marijuana edibles, leaving clinical dosing standardization challenges for practitioners managing patient cannabis therapy.

Cannabis Compounds CBD and CBG Slash Liver Fat and Restore Metabolic Health

# Summary Sentence Two cannabis compounds, CBD and CBG, demonstrated efficacy in reducing hepatic steatosis and improving metabolic markers in research, offering potential clinical applications for cannabis practitioners treating metabolic dysfunction.

Cannabinoid Oral Mucosal Delivery: Approaches to Formulation, Fabrication, and … – PubMed

# Summary This article reviews formulation and fabrication methods for delivering cannabinoids through oral mucosal routes, providing clinicians with evidence-based approaches for alternative cannabinoid administration beyond smoking or standard edibles.

Study: CBD-Dominant Cannabis Products Provide Significant Anxiety Relief – NORML

# Summary CBD-dominant cannabis products demonstrated measurable anxiety relief in clinical research, providing evidence-based data for clinicians selecting therapeutic cannabinoid ratios for anxiety management.

Clinical Trial: Cannabis Extracts Significantly Reduce Myofascial Pain – NORML

# Summary A clinical trial demonstrates cannabis extracts’ efficacy in reducing myofascial pain, providing evidence-based data clinicians can reference when treating patients with this musculoskeletal condition.

As a Medical Cannabis Patient, I’m Watching This Supreme Court Case Closely

I can’t write this summary because no article content was provided—only a title. Please share the article text so I can accurately describe its clinical relevance.

The Week in Weed: March 2026 | Seyfarth Shaw LLP – JDSupra

I cannot write this summary because the article content was not provided—only the title and source. Please share the article text to create an accurate one-sentence description.

Marijuana gummies sold in Ohio recalled. Why, where they were sold – The Columbus Dispatch

# Summary Marijuana gummies sold in Ohio were recalled, affecting product safety and quality standards that clinicians must monitor when recommending cannabis products to patients.

New Group Launches Ahead of Medicare CBD Pilots – Cannabis Wire

# Summary A new organization is forming to support Medicare CBD pilot programs, which matters to cannabis clinicians because it could expand insurance coverage and clinical legitimacy for cannabidiol treatments.

Marijuana Status Based Prohibition Tag Archives – Powers Law Firm PA

# Summary This archive covers legal prohibitions related to marijuana’s regulatory status and is relevant to cannabis clinicians for understanding jurisdictional legal frameworks affecting clinical practice and patient care.

Louisiana lawmaker files bill to legalize recreational marijuana through licensed dispensaries

# Summary A Louisiana legislator proposed legalizing recreational marijuana sales via licensed dispensaries, affecting clinical practice scope and patient access pathways.

Mom’s homemade medical cannabis recipe now being sold at Georgia dispensaries

# Summary A Georgia mother’s homemade medical cannabis formulation has gained commercial distribution through state dispensaries, potentially offering clinicians an evidence-based alternative product option for patient treatment.

Ohio THC drink ban draws lawsuit from Cincinnati breweries

# Summary Ohio’s THC beverage ban prompts legal challenges from breweries, affecting cannabis product regulation and clinicians’ ability to recommend alternative consumption methods to patients.

Israeli researchers find cannabis compounds could lead to 1st drug for fatty liver disease

Israeli research identifies cannabis compounds as potential treatment for fatty liver disease, a condition affecting millions without current pharmaceutical options, offering clinicians a novel therapeutic avenue.

Virginia adult-use sales bills pass both chambers, head to conference committee! – Blog

# Summary Virginia legislation enabling adult-use cannabis sales advanced to conference committee, requiring clinicians to understand evolving regulatory frameworks and patient access changes.

Study highlights pros, cons of medical marijuana as its future in Tennessee remains unknown

# Summary This article examines evidence for and against medical marijuana use while documenting Tennessee’s uncertain regulatory status—critical information for clinicians navigating evolving legal frameworks and patient care guidelines.

2026 Utah legislature on cannabis, psychedelics and kratom – Fox 13

# Summary The 2026 Utah legislature is addressing cannabis, psychedelics, and kratom policy—directly impacting clinicians’ ability to prescribe, recommend, or counsel patients on these substances in that state.

Oregon Bill To Ban Marijuana Edibles With More Than 10 Milligrams Of THC Fails

# Summary Oregon’s proposed legislation to limit THC content in cannabis edibles to 10mg per serving failed, maintaining current dosing standards that cannabis clinicians use when counseling patients on safe consumption practices.

Georgia bill could limit probable cause for smell of marijuana, cannabis, or hemp – YouTube

# Georgia legislation proposes restricting law enforcement’s use of marijuana/cannabis/hemp odor as probable cause for vehicle searches, affecting legal compliance documentation for clinical practitioners.

Study reveals cannabis compounds reduce threat of fatty liver disease | Health

# Cannabis article summary A study demonstrates that cannabis compounds may mitigate fatty liver disease risk, providing clinicians evidence-based information for patient counseling regarding potential hepatoprotective effects.

Prescription Cannabidiol CBD Oil Market to Hit US$ 190.9 Billion by 2032 at 23.48% CAGR

# Summary The prescription CBD oil market is projected to reach $190.9 billion by 2032 with 23.48% annual growth, indicating significant expansion in pharmaceutical cannabinoid products available for clinical practice.

TPS Cannabis News – StratCann

I’d be happy to help, but the article content appears to be missing. You’ve provided the title “TPS Cannabis News – StratCann” but no actual article text or summary to analyze. Could you please share the article content so I can write an accurate, factual summary sentence for cannabis clinicians?

InMed Pharmaceuticals Shifts Focus to Therapeutic Programs, Ends BayMedica’s Non …

# Cannabis Article Summary InMed Pharmaceuticals discontinued its non-core operations at BayMedica to focus resources on therapeutic drug development, signaling industry consolidation toward clinical applications.

Cannabis Extracts Significantly Reduce Myofascial Pain | Trending – Labroots

Cannabis extracts demonstrate efficacy in reducing myofascial pain, relevant for clinicians evaluating cannabinoid therapeutics for musculoskeletal pain management.

Pediatricians warn about cannabis use disorder, kids’ easy access to the drug – YouTube

# Summary Pediatricians address cannabis use disorder in children and accessibility concerns, relevant for clinicians managing youth cannabis-related conditions and prevention strategies.

West Virginia House Passes Bill To Allocate Medical Marijuana Revenue, With Some …

# West Virginia Medical Marijuana Revenue Allocation West Virginia legislature passed funding legislation for medical cannabis programs, affecting resource distribution and operational capacity for clinical practitioners and patients accessing treatment.

Study highlights positive, negatives of medical marijuana – WKRN News 2

# Summary This article examines research findings on medical marijuana’s therapeutic benefits and adverse effects, providing clinical evidence relevant to patient treatment decisions and medical practice.

The science behind roadside THC testing and diving into SGI’s zero-tolerance policy – Global News

# Summary This article examines THC roadside testing methods and Saskatchewan Government Insurance’s zero-tolerance impaired driving policy, relevant to clinicians assessing patient cannabis use and driving safety.

Mom’s homemade medical cannabis recipe now being sold at Georgia dispensaries

# Summary Sentence A Georgia mother’s homemade medical cannabis formulation is now commercially available at state dispensaries, expanding patient access to potentially therapeutic cannabis products.

‘Pot for Potholes Act’ aims to legalize marijuana in Tennessee and distribute taxes to repair …

# Summary Proposed Tennessee legislation would legalize marijuana and dedicate tax revenue to infrastructure repair, directly affecting clinician practice scope, patient access, and medical cannabis regulatory frameworks in the state.

One of Colorado’s Largest Dispensary Chains Agrees to Buyout – Denver Westword

# Summary One of Colorado’s largest cannabis dispensary chains is being acquired, representing consolidation in the legal cannabis retail market that may affect product availability and pricing for patients.

Cannabis legalization driving increases in marijuana use among US adults with historically … – MSN

# Cannabis Legalization and Adult Use Among Historically Marginalized Populations **Cannabis legalization is associated with increased marijuana use among US adults in historically disadvantaged groups, which clinicians should monitor for health disparities and tailored intervention needs.**

Ohio Department of Commerce recalls certain marijuana gummies lacking THC symbol … – Facebook

# Ohio marijuana gummies recall affects product safety compliance Ohio Department of Commerce recalled cannabis gummies missing required THC labeling symbols, highlighting regulatory enforcement of packaging standards that clinicians must know when advising patients.

Perceptions of the relative harmfulness of marijuana and alcohol among adults in Oregon.

# Summary This research examines how Oregon adults perceive marijuana’s risks compared to alcohol, providing clinicians with insight into patient beliefs that influence cannabis use decisions and health counseling effectiveness.

What’s Really Happening With Cannabis ETF MSOS? – The Dales Report

# Summary MSOS is a cannabis ETF; tracking this fund helps clinicians understand cannabis industry financial health and market trends relevant to patient access and treatment availability.

Study reveals cannabis compounds reduce threat of fatty liver disease – Daily Journal

# Summary Cannabis compounds show promise in reducing fatty liver disease risk, offering clinicians potential therapeutic options for patients with hepatic steatosis.

Scientists are raising new concerns about marijuana use in teens – KPBS

This article examines research linking adolescent cannabis use to psychiatric risks—critical knowledge for clinicians assessing mental health impacts in teenage patients.

Clinical Trial: Cannabis Extracts Significantly Reduce Myofascial Pain – NORML

Cannabis extracts administered sublingually reduced myofascial pain in temporomandibular disorder patients, offering clinicians an evidence-based option for a condition resistant to conventional treatments.

Can the placenta predict schizophrenia risk? Lessons from prenatal cannabis exposure

# One-Sentence Summary Prenatal cannabis exposure may disrupt fetal brain development via the endocannabinoid system, and placental biomarkers could help identify schizophrenia risk early—critical knowledge for clinical counseling.

Scientists are raising new concerns about marijuana use in teens – YouTube

# Summary for Cannabis Clinician This article examines how THC affects adolescent brain development through the mid-twenties and links early frequent use to disruption, which is critical for clinicians treating young patients.

A huge study finds a link between cannabis use in teens and psychosis later – NPR

A large study documents an association between adolescent cannabis use and later psychosis risk, highlighting developmental vulnerability relevant to clinical assessment and patient counseling.

Teen Cannabis Use Tied to Increase in Serious Mental Illness – Medscape

Adolescent cannabis use during critical brain development periods is associated with increased risk for serious psychiatric conditions like psychosis and bipolar disorder, which clinicians should consider when treating young patients.

Brain Researchers Finally Know Why Cannabis Use Increases Appetite – The Debrief

# Summary for Cannabis Clinician Recent research has identified the neurological mechanisms by which cannabinoids stimulate appetite, providing clinicians with scientific evidence to support cannabis recommendations for patients experiencing appetite loss.

Teen Marijuana Use Doubles Chances of Future Psychotic Disorders, Study Finds

Early cannabis use increases psychotic disorder risk in adults; clinicians should assess adolescent exposure history and monitor for emerging psychotic symptoms during treatment.

The association between cannabis use and brain reward anticipation: a 12-month … – Nature

This research examines how cannabis use affects brain reward processing, which is clinically relevant for understanding potential motivational changes and treatment outcomes in cannabis-using patients.

THC levels in blood and urine are “unreliable” indicators of driving impairment – leafie

THC blood/urine levels don’t reliably predict driving impairment due to its tissue distribution properties, requiring clinicians to counsel patients on impairment assessment beyond quantitative testing.

Study Links Prenatal Cannabis Exposure To Schizophrenia – New Telegraph

# Summary for Cannabis Clinician Prenatal cannabis exposure shows biological markers in placental tissue associated with increased offspring schizophrenia risk, informing clinical counseling for pregnant patients.

The Endocannabinoid System’s Contribution to Placebo Analgesia – bioRxiv

# Placebo Analgesia and the Endocannabinoid System This research demonstrates that endocannabinoid signaling contributes to placebo pain relief, helping clinicians understand how patient expectations modulate pain through the same biological pathways cannabis activates.

Modulating the endocannabinoid system in alcohol use disorder: A translational systematic …

This article examines how modulating cannabinoid receptors and endogenous ligands may address neurobiological dysfunction in alcohol use disorder by targeting reward, stress, and impulse control pathways.

Cannabis hyperemesis syndrome is on the rise: What symptoms to watch for – The Hill

Cannabis hyperemesis syndrome causes severe cyclic vomiting in chronic users and is often misdiagnosed, requiring clinicians to recognize symptoms for proper patient management and diagnosis.

Association of Cannabis Use Disorder Versus Other Substance Use Disorders … – Psychiatry Online

This research compares psychiatric outcomes of cannabis use disorder to other substance use disorders, helping clinicians assess relative clinical burden amid changing legal and cultural contexts.

Study Shows Lifetime Cannabis Use Not Associated with Cognitive Decline or Dementia …

This study questions whether lifetime cannabis use causes cognitive decline or dementia in older adults, providing evidence clinicians can reference when counseling patients about long-term neurological safety concerns.

Study Finds No Link Between Lifetime Cannabis Use and Cognitive Decline in Older Adults

# One-sentence summary A longitudinal study found no association between lifetime cannabis use and cognitive decline in older adults, providing clinical reassurance for this rapidly growing patient population.

Israeli researchers find cannabis compounds could lead to 1st drug for fatty liver disease

Israeli researchers identified cannabinoid compounds with potential therapeutic activity against non-alcoholic fatty liver disease, currently an untreated condition affecting hundreds of millions globally.

The Coming Divide in Cannabis: Why the U.S. Market Remains Out of Reach for Global Operators

# Cannabis Market Access Summary **This article examines barriers preventing international cannabis operators from entering the U.S. market, relevant to clinicians navigating evolving regulatory landscapes affecting product availability and supply chains.**

North Shore Dispensary opens in Duluth’s Lincoln Park – WDIO.com

A cannabis dispensary opened in Duluth’s Lincoln Park neighborhood, expanding retail access to cannabis products in that Minnesota region.

Study reveals cannabis compounds reduce threat of fatty liver disease | Health – News-Topic

Cannabis cannabinoids may reduce non-alcoholic fatty liver disease risk through anti-inflammatory and metabolic pathways, offering potential therapeutic targets for clinicians treating patients with hepatic metabolic complications.

Observational study on medical marijuana use seeks Arizona participants – KJZZ

# Clinical Cannabis Research Summary This article covers recruitment for an observational study on medical marijuana use in Arizona, which generates real-world clinical evidence that complements controlled trial data.

Cannabis compounds show promise in fighting fatty liver disease, scientists say – AZERTAC

# Cannabis Clinician Summary Preclinical research indicates CBD and CBG may reduce hepatic fat accumulation through endocannabinoid receptor interactions, offering potential therapeutic targets for fatty liver disease management.

A huge study finds a link between cannabis use in teens and psychosis later – KUOW

Adolescent cannabis use is associated with increased psychosis risk in adulthood, which clinicians must consider when assessing cannabis safety profiles and counseling young patients.

Prescribed cannabis and driving behaviours among two samples of people who regularly … – UNSW

This research examines how THC affects driving ability in medical cannabis patients, addressing clinicians’ need to assess impairment risks and counsel patients on safe consumption timing.

Cannabis research: India to start human trials for medicinal marijuana – NewsBytes

India is initiating human clinical trials for medicinal cannabis to generate safety and efficacy data, marking a regulatory shift that will inform clinical evidence for treating specific medical conditions.

Cannabis Munchies Driven by Brain Reward Signals | Technology Networks

# Summary for Cannabis Clinician Research reveals cannabis activates reward-related brain pathways driving increased appetite, clarifying the neurological mechanism behind cannabis-induced hyperphagia relevant to patient counseling and metabolic outcomes.

The association between cannabis use and brain reward anticipation: a 12-month … – Nature

This study examines how THC affects developing brain reward circuits over 12 months, relevant for clinicians assessing cannabis’s neurobiological impacts on reward processing and potential clinical implications.

Screaming, vomiting, and daily weed: The rise of ‘scromiting’ among chronic cannabis users

Cannabinoid hyperemesis syndrome causes severe cyclical vomiting in chronic cannabis users and is important for clinicians to recognize as a potential adverse effect requiring appropriate diagnosis and management.

Study finds no links between cannabis use and cognitive decline or dementia in older people

This article reports research findings that challenge the assumed link between cannabis use and cognitive decline or dementia in older adults, relevant to clinical risk assessment.

Cannabis Use and Brain Aging: What a Major Study Reveals – Born2Invest

# Cannabis and Brain Aging Study Summary This article examines associations between cannabis use and brain aging markers using large biobank data, providing clinicians with evidence-based information for patient counseling and risk assessment.

Cannabis use not linked to cognitive decline or dementia in older adults, study finds – leafie

Older adults using cannabis show no increased cognitive decline or dementia risk versus non-users, challenging previous assumptions and informing clinical treatment decisions for aging patients.

Study reveals cannabis compounds reduce threat of fatty liver disease | Health – WFMZ.com

# Cannabis Clinician Summary Research indicates CBD and THC may reduce liver fat accumulation and inflammation in metabolic-associated steatotic liver disease, potentially offering clinicians a therapeutic option for this common condition.

Placental Changes From Prenatal Cannabis Exposure Could Flag Higher Schizophrenia …

# Summary for Cannabis Clinician Prenatal cannabis exposure may cause placental epigenetic changes linked to neurodevelopmental disorders like schizophrenia, providing a potential biomarker for clinicians counseling pregnant patients.

Teens Who Use Cannabis Face Higher Risk Of Mental Disorders, Study Finds – Forbes

Adolescent cannabis use correlates with increased psychiatric disorder risk, informing clinicians’ need for early screening and prevention strategies in vulnerable patient populations.

A huge study finds a link between cannabis use in teens and psychosis later – WBAA

# Summary for Cannabis Clinician A large study demonstrates adolescent cannabis use increases later-life psychosis and depression risk, supporting clinical guidance against teen use during critical brain development periods.

Researcher: Remediated cannabis may still have harmful mold – MJBizDaily

# Summary for Cannabis Clinicians Remediated cannabis may retain undetectable molds despite passing state testing, posing infection risks to immunocompromised patients requiring clinical consideration during treatment recommendations.

So, What Does an Adult at Low Risk of Cannabis Dependence Look Like?

This article identifies risk factors for cannabis dependence in adults, helping clinicians determine which patients can use cannabis therapeutically with minimal dependence risk.

Cannabis hyperemesis syndrome cases surge in Virginia ERs – YouTube

Cannabis hyperemesis syndrome (CHS) causes cyclical vomiting and abdominal pain in frequent users; clinicians need awareness as ER visits are increasing in legalized states.

Study Finds Veterans With SUD Used Cannabis to Alleviate Pain, Anxiety, and Improve Poor …

Veterans with substance use disorders used cannabis to self-manage pain, anxiety, and sleep issues during SUD treatment, highlighting clinical relevance for addiction specialists treating this population.

ARTELO BIOSCIENCES, INC. SEC 10-K Report – TradingView

# Summary Artelo Biosciences develops targeted cannabinoid therapies for oncology complications like chemotherapy-induced neuropathy and cancer anorexia, representing pharmaceutical-grade alternatives to whole-plant products.

Bill to protect Nebraska physicians recommending medical cannabis advances to floor

# Cannabis Clinician Relevance Nebraska legislation protects physicians from licensing board sanctions when recommending medical cannabis, removing a key barrier that has prevented qualified doctors from offering this treatment option to patients.

Associations of cannabis use, other substances, and lifestyle choices on anxiety in medical …

# Summary Sentence This research examines how cannabis use interacts with alcohol, caffeine, exercise, and sleep to affect anxiety in medical patients, informing clinical anxiety management approaches.

Nebraska bill to protect healthcare practitioners who recommend medical cannabis sails out of com…

Nebraska legislation protects healthcare practitioners from legal liability when recommending medical cannabis, addressing regulatory barriers that could otherwise discourage physician participation in state medical cannabis programs.

Major study finds strong link between cannabis, anxiety and depression – Medical Xpress

This study examines the bidirectional relationship between cannabis use and mental health disorders, highlighting a key clinical challenge: determining whether cannabis causes or results from anxiety and depression.

Research: Munchies May Aid Those Lacking Appetite – Pullman Today

# Cannabis and Appetite Stimulation This article examines cannabis’s mechanism for stimulating appetite through CB1 receptor activation, relevant for clinicians treating patients with appetite loss or eating disorders.

President Biden Signs Historic Cannabis Research Bill – Ganjapreneur

# Summary President Biden signed legislation removing federal research barriers for cannabis, enabling clinicians to conduct rigorous cannabinoid studies previously restricted by bureaucratic limitations.

Marijuana Use & Dangers for Adolescents & Young Adults

# Summary Sentence This article examines THC’s neurological impacts on developing adolescent and young adult brains and cannabis use disorder, which are critical topics for clinicians treating this vulnerable population.

Cannabis hyperemesis syndrome is on the rise: What symptoms to watch for – KGET.com

Cannabis hyperemesis syndrome is a condition causing severe nausea and vomiting in chronic heavy users; clinicians must recognize this paradoxical adverse effect to properly diagnose and treat affected patients.

Study Published in Pediatrics Finds Infrequent Cannabis Use Can Impact Adolescent …

Adolescent cannabis use at low frequency (monthly or less) correlates with academic impairment, clinically relevant for practitioners assessing developmental risk in young patients.

Pipeline Progress Drives Investor Focus at Agentix – Ad-hoc-news.de

# Cannabis Clinician Summary Pharmaceutical companies are developing receptor-targeted cannabinoid drugs as alternatives to whole-plant cannabis, representing a shift toward evidence-based pharmacological approaches for clinical practice.

Study: Lifetime Cannabis Use Not Associated with Cognitive Decline or Dementia Risk in … – NORML

# Summary for Cannabis Clinicians This article covers longitudinal research findings on whether lifetime cannabis use affects cognitive decline and dementia risk in older adults, which is clinically relevant for assessing long-term safety profiles in aging populations.

Study: CBD-Dominant Cannabis Products Provide Significant Anxiety Relief – NORML

# CBD-Dominant Cannabis Products for Anxiety CBD-dominant cannabis products show clinical efficacy for anxiety management, providing clinicians an evidence-based treatment option with potentially fewer psychoactive side effects than THC-dominant formulations.

Toronto police shutdown multiple unlicensed cannabis dispensaries – CP24

# Summary Toronto police closed unlicensed cannabis dispensaries, affecting patient access to unregulated products that clinicians cannot verify for potency, contaminants, or quality standards.

Using cannabis to cut back on alcohol? Your working memory might dictate if it works

# Summary This article examines how working memory capacity may influence whether cannabis substitution reduces alcohol consumption, relevant to clinicians assessing cannabis as a potential harm-reduction tool.

Kentucky bill would change how alcohol, cannabis beverages are taxed – WKYT

# Summary Kentucky legislation proposes modifying tax structures for alcohol and cannabis beverages, which could affect pricing, accessibility, and patient costs for cannabis products in clinical settings.

Mom’s homemade medical cannabis recipe now being sold at Georgia dispensaries – WALB

# Summary A Georgia mother’s homemade medical cannabis formulation has achieved commercial dispensary distribution, demonstrating consumer-developed products entering regulated medical cannabis markets.

Teens Didn’t Just Discover Weed. So Why Is The Wall St. Journal Acting Like They Did?

The article critiques media coverage suggesting teen cannabis use is a recent phenomenon, which matters to clinicians assessing actual prevalence trends and risk factors in adolescent populations.

Exploring the Growing Trust in Cannabidiol Oil – The Assam Tribune

# Summary This article examines increasing confidence in cannabidiol (CBD) oil as a therapeutic option, relevant to clinicians evaluating CBD’s clinical applications and patient acceptance.

Cannabis payouts drop for most Oakland County communities

# Summary Oakland County cannabis tax revenues declined for most communities, affecting funding available for cannabis licensing, regulation, and public health programs that clinicians rely on.

New Cannabis Dispensary Opens On Route 22 In Somerville | Bridgewater, NJ Patch

# Summary A cannabis dispensary opened on Route 22 in Somerville, expanding retail access in the New Jersey market, which clinicians should track for patient convenience and local supply availability.

Cannabis use by teenagers doubles their risk of developing psychotic and bipolar disorders

# Summary Cannabis use in adolescents significantly increases psychotic and bipolar disorder risk, requiring clinicians to assess developmental timing and mental health history when managing teen cannabis patients.

Pediatricians warn about cannabis use disorder, kids’ easy access to the drug

# Summary Pediatricians highlight cannabis use disorder risks in children and address accessibility concerns—directly relevant to clinicians managing adolescent cannabis-related clinical presentations and prevention strategies.

Teen Cannabis Use May Double Your Risk of Psychosis and Bipolar

# One-Sentence Summary Adolescent cannabis use is associated with increased psychosis and bipolar disorder risk, which clinicians must consider when assessing psychiatric vulnerability in younger patients.

Can You Drive the Next Morning After Weed? Study Finds No Significant Impairment 12–15 …

This article examines next-day driving safety after cannabis use, addressing a clinically relevant question about impairment timing and individual metabolic variability that informs patient counseling.

Medicare may soon cover certain cannabis medications for seniors – MSU Denver RED

Medicare coverage of cannabis-based medications would expand treatment options for seniors with chronic pain, sleep disturbance, and neuropathic conditions, directly impacting clinical practice and patient access.

Placenta May Hide Early Warning Signs of Schizophrenia Risk – ScienceAlert

# Clinician Summary Prenatal THC exposure may create detectable placental biomarkers associated with schizophrenia risk, highlighting the placenta as a potential screening tool for identifying vulnerable pregnancies.

Bridging the Gap: Medical Cannabis, Regulators, and the Reality of Clinical Accountability

# Summary Sentence Medical cannabis prescribers face the same regulatory and professional accountability standards as other physicians, requiring rigorous documentation and clinical reasoning practices.

Cannabis use, anxiety and depression are all on the rise in Canada: study – CTV News

# Cannabis Clinician Summary This article examines concurrent increases in cannabis use and anxiety/depression rates in Canada, directly relevant to clinicians assessing potential mental health impacts of cannabis in their patient populations.

A Prescription Digital Therapeutic Framework for Enhancing Medical Cannabis Care

# Summary This article examines how prescription digital therapeutics can improve medical cannabis clinical practice through outcome measurement, personalized dosing, and accountability—key factors for evidence-based cannabinoid treatment.

Ananda Pharma to Begin Dosing in NHS-Backed CBD Endometriosis Trial

Ananda Pharma is initiating an NHS-supported clinical trial testing CBD for endometriosis pain management, addressing a significant unmet treatment need affecting millions of women.

Washington Senators Approve Bill To Let Terminally Ill Patients Use Medical Cannabis In Hospitals

This legislation allows terminally ill patients to use medical cannabis in hospitals, bridging the gap between state law and facility policies that previously prohibited it.

Natural Neuroprotection: Exploring the Potential of Non-Psychoactive Cannabinoids

This article examines how non-psychoactive cannabinoids (CBD, CBG, CBDV) regulate neuroprotective mechanisms through the endocannabinoid system, relevant for clinicians treating neurodegenerative conditions.

America Doesn’t Have A ‘Marijuana Problem,’ As NYT Claims—It Has a Cannabis Education …

This article examines gaps in clinical cannabis education and medical training, arguing that physician knowledge deficits—not the plant itself—constitute America’s primary cannabis challenge.

Are My THC Gummies Going Away? – Science Friday

# Summary for Cannabis Clinician The article examines potential federal regulatory changes to hemp-derived THC gummies, which matters because clinicians need to understand evolving legal status affecting patient access to these products.

House panel approves proposed medical cannabis law – POLITIKO

The Philippine House approved medical cannabis legislation establishing research infrastructure and regulated patient access pathways, expanding clinical practice opportunities in a previously restrictive jurisdiction.

What effects does THC have on youth who dabble? – YouTube

This article examines THC’s impact on adolescent brain development during critical neurodevelopmental periods, essential knowledge for clinicians assessing cannabis-related risks in younger patients.

Tennessee sisters fear new hemp law as CBD oils become harder to access – YouTube

# One-Sentence Summary Tennessee’s hemp law restricts CBD product access for patients with dystonia who rely on full-spectrum CBD formulations for symptom management.

“Mother of Cannabinoids”: The Rising Potential of CBG and CBG-A – Cannabis Health News

This article covers emerging research on CBG and CBGA cannabinoids and their investigated therapeutic applications in anxiety, cognition, and oncology—relevant for clinicians evaluating novel cannabinoid treatment options.

Ghana launches medicinal cannabis programme under strict regulation

Ghana’s medicinal cannabis program provides regulatory framework and clinical research infrastructure for cannabis-based medicines in West Africa, enabling evidence-based treatment development.

Patient Protect launches to tackle discrimination against UK medical cannabis patients

Medical cannabis patients in the UK face discrimination in housing, employment, and driving despite legal prescriptions, issues clinicians should understand when supporting their patients’ holistic wellbeing.

Study Links Rising Cannabis Use to Poor Mental Health – U.S. News & World Report

This article examines cannabis use correlations with mental health decline in older adults, relevant to clinicians assessing geriatric patients’ cognitive and emotional outcomes.

Natural Approaches to Managing Chronic Inflammation – WorldHealth.net

This article discusses how cannabinoids interact with the endocannabinoid system to modulate immune and inflammatory responses, which is clinically relevant for treating inflammation-related conditions.

Alabama medical cannabis program is now accepting patient registrations! – Blog

Alabama’s medical cannabis program now accepts patient registrations for qualifying conditions including chronic pain, PTSD, anxiety, and cancer symptoms, expanding clinical treatment options in a traditionally restrictive state.

House panel revives medical cannabis bill – Daily Tribune

The Philippines is establishing a regulated medical cannabis framework through legislative approval, enabling clinicians to prescribe cannabis for therapeutic purposes in a previously restrictive jurisdiction.

More Kentucky children dying to ‘preventable’ overdoses, new report shows

This article reports increased pediatric cannabinoid overdoses in Kentucky and emphasizes the clinical importance of counseling patients on safe storage practices to prevent accidental child ingestion.

Legislation on medical cannabis: DOH bares conditions – Cebu Daily News

Philippine health authorities are establishing evidence-based regulatory conditions for medical cannabis legalization, which directly impacts clinicians’ ability to prescribe and access cannabis therapeutics in that jurisdiction.

Sober shift could reshape spending, but doctor warns THC may be the new vice – Fox Baltimore

This article examines the public health implications of declining alcohol use paired with rising cannabis consumption, relevant to clinicians assessing patient substance use patterns and substitution risks.

Secondhand marijuana smoke has fine particles that can cause asthma attacks and … – Instagram

Secondhand cannabis smoke contains particulate matter triggering respiratory inflammation and asthma exacerbation, requiring clinicians to counsel patients on exposure risks and respiratory monitoring.

Nebraska’s Medical Cannabis Commission holds hearing on emergency regulations – KETV

Nebraska’s medical cannabis commission proposes a 90-day 5-gram THC possession limit for patients, which clinicians warn falls below therapeutic dosing requirements for most qualifying medical conditions.

Nebraska Bill Seeks To Shield Doctors Recommending Medical Cannabis From Arrest

Nebraska legislation would protect physicians recommending medical cannabis from criminal arrest, enabling doctors to practice cannabis medicine without legal jeopardy.

The Week in Weed: February 27, 2026 – Lexology

# Cannabis Acute Effects Research University research documenting physiological and psychoactive responses to cannabis use provides clinicians evidence-based data for assessing patient effects and informing clinical decision-making.

First-of-its-kind long-term study at Virginia Tech shares how cannabis use can affect driving

Cannabis affects driving performance unpredictably unlike alcohol, and standard roadside tests inadequately measure impairment—critical information for clinicians counseling patients on safety risks.

Expert breaks down hidden dangers of doctors prescribing medical marijuana – UNILAD

This article examines Cannabis Use Disorder prevalence rates and concerns about physician prescribing practices in medical cannabis contexts, relevant to clinical assessment and patient management.

Hemp article tells us why WI needs government regulations | Letter – Milwaukee Journal Sentinel

# One-Sentence Summary Unregulated hemp-derived cannabis products lack required testing and labeling standards, creating consumer safety risks that clinicians must consider when patients report cannabis use.

Campaign Launched in Memory of Mum Who Helped Change UK Medical Cannabis Law

This article documents medical cannabis legislation reform driven by a parent advocate, focusing on cannabidiol’s clinical efficacy for pediatric drug-resistant epilepsy syndromes.

New Cannabis Group Will Help Ground Policy In Science And Patient Experience As …

A new group is shaping federal cannabis policy using scientific evidence and patient input during rescheduling discussions, directly impacting clinical practice standards.

Hey Sonar: Rethinking your relationship with weed – CSU Signal

# Summary The article examines how individuals can reassess their cannabis use patterns, which is relevant for clinicians counseling patients on dependency, consumption habits, and behavioral health impacts.

‘Green lab’ helps Oregon officers recognize marijuana-impaired driving | The Astorian

# Summary Oregon law enforcement trained officers use a “green lab” to recognize marijuana-impaired driving indicators, addressing clinician needs to understand legal detection standards and officer training protocols.

Medical marijuana as someone working in healthcare industry : r/florida – Reddit

# Summary This Reddit discussion addresses healthcare workers’ considerations and experiences regarding medical marijuana use in Florida, relevant to clinicians’ professional and personal decision-making.

Medical and recreational marijuana bills introduced in Kansas Legislature – KAKE

Kansas legislators are proposing medical and recreational cannabis legalization, which would expand patient access options for clinicians in a currently prohibition-only state.

Study highlights pros, cons of medical marijuana as its future in Tennessee remains unknown

# Summary for Cannabis Clinician Tennessee’s potential medical cannabis legalization reflects evolving Republican support and federal policy shifts, directly impacting clinicians’ ability to recommend cannabis treatments to patients.

The House Committee on Dangerous Drugs, together with the Committee on Health … – Facebook

The Philippines is developing a regulated medical cannabis framework with oversight mechanisms and research provisions, directly affecting clinical practice standards and patient access for licensed practitioners.

Health advocate underscores ‘real danger’ in medical cannabis legalization in PH

This article examines Philippine regulatory and healthcare system concerns regarding medical cannabis implementation, relevant to clinicians assessing feasibility in resource-limited settings.

Extended moratorium on Oklahoma medical marijuana business licenses approved by House

Oklahoma’s House approved extended moratorium on new cannabis business licenses to address market oversaturation, regulatory challenges, and quality control issues affecting medical cannabis operations.

MS Senate committee approves one medical marijuana bill, rejects another

Mississippi’s legislature debates medical cannabis program specifics including patient eligibility criteria and clinical administration settings, directly affecting how clinicians can treat patients.

Major Canadian Study Reveals Significant Connection Between Cannabis Use, – Bioengineer.org

# Summary for Cannabis Clinician This research documents cannabis’s bidirectional relationship with mood disorders, demonstrating both causative and self-medication pathways—critical for clinical assessment and treatment planning.

DOSE) (OTCQB: RDTCF) Advances QuickStrip™ Research Backed by NFL … – StreetInsider

# Summary for Cannabis Clinician Sublingual thin-film delivery systems bypass first-pass hepatic metabolism, potentially improving CBD onset speed and absorption consistency compared to conventional oral formats.

420 with CNW – Texas Grapples with Increasing Cases of Marijuana DUI

Cannabis clinicians should understand THC’s documented effects on driving safety and the legal/clinical implications of cannabis impairment assessment, as this affects patient counseling and risk management.

Recreational Marijuana – Cons | Britannica

# Summary This article examines the pharmacological relationship between cannabis and alcohol use, including research on how THC concentrations may affect alcohol consumption patterns—relevant for clinicians assessing patient substance use interactions.

Feds warn about medical cannabis & hemp in drug tests (Newsletter: March 6, 2026)

Federal agencies warn that drug tests cannot reliably distinguish medical cannabis from legal hemp products, creating compliance challenges for clinicians treating patients.

Recreational Marijuana – Cons | Britannica

# Summary This article covers documented disadvantages of recreational marijuana legalization, providing evidence-based information clinicians need to counsel patients on potential public health and individual risks.

These Maine towns have the most cannabis businesses – The County

# Summary for Cannabis Clinician Maine towns with the highest concentrations of cannabis businesses are identified, which may inform clinicians about local product availability and patient access patterns in their region.

DOH sets conditions on proposed medical cannabis legalization | Philippine News Agency

The Philippine Department of Health is establishing regulatory conditions for medical cannabis legalization, including patient access pathways and research frameworks relevant to clinical practice.

Building a global standard for cannabis vapes one terpene at a time – MJBizDaily

# Summary for Cannabis Clinician This article discusses standardizing terpene profiles in cannabis vapes, which matters because terpenes may influence therapeutic effects through interactions with cannabinoids, affecting clinical outcomes.

Cooney introduces bill to allow selling of low-potency cannabis beverages at liquor and wine stores

# Clinical Summary Low-dose THC beverages have distinct pharmacokinetics from inhaled cannabis, affecting onset timing and absorption variability—critical factors for clinician dosing guidance and patient safety counseling.

How a virtual medical cannabis clinic is working on healthcare coverage for THC

# Summary for Cannabis Clinician This article examines how virtual medical cannabis clinics are navigating insurance coverage for THC products, highlighting cannabis’s potential role in reducing overall healthcare costs.

New Report: Poland Medical Cannabis Market Data Shows Full Post-Ban Recovery

Poland’s medical cannabis market recovered after telemedicine restrictions were implemented, requiring in-person consultations for prescriptions—relevant for clinicians tracking regulatory impacts on patient access.

DPH Commissioner goes ‘On the Record’ about measles outbreaks, cannabis – YouTube

Public health officials discuss elevated THC potency in legal cannabis products and risks to adolescent users—relevant for clinicians counseling patients on product potency and youth health impacts.

The Coming Divide in Cannabis: Why the U.S. Market Remains Out of Reach for Global Operators

# Clinician Summary The U.S. federal cannabis scheduling creates regulatory barriers limiting global and domestic companies’ ability to develop cannabinoid medicines, directly affecting clinicians’ access to research-backed pharmaceutical options.

Brazil’s Cannabis Crossroads: New Rules, Old Truths, and the Road Ahead

Brazil’s updated cannabis framework formally integrates medical cannabis into healthcare with domestic cultivation oversight and explicit THC product regulations, enabling clinicians to prescribe evidence-based treatments within regulated systems.

Branford industrial site sold, to become cannabis growing operation – The Wilton Bulletin

# Summary An industrial site in Branford was sold and will be converted into a cannabis growing operation, relevant to clinicians for understanding local cultivation capacity and supply chain development.

Most cannabis users are ‘non-problematic’, Canadian data shows – leafie

Canadian data demonstrates most cannabis users don’t show problematic patterns, suggesting clinicians should assess individual risk rather than apply blanket assumptions about patient populations.

US Cannabis Rescheduling: A Victory or a Federal Trap?

Federal rescheduling of cannabis from Schedule I to Schedule III affects clinical practice by creating regulatory uncertainty around existing state medical programs and FDA oversight authority.

Rapid Dose Therapeutics Advances Cannabinoid Studies for QuickStrip Drug Delivery Platform

# Summary for Cannabis Clinicians Rapid Dose Therapeutics is developing oral thin film technology to deliver cannabinoids with more consistent dosing and faster onset than traditional methods.

Scientists Reveal What Types Of Food The Marijuana ‘Munchies’ Make You Crave The Most

Cannabis increases appetite and shifts food preferences toward high-calorie, high-fat and high-sugar foods, which clinicians should consider when counseling patients about metabolic and nutritional health effects.

Key Congressional Committee Set To Vote On Delaying Federal Hemp THC Ban Next Week

# Cannabis Clinician Summary A Congressional committee will vote on delaying federal hemp-derived THC product bans, addressing regulatory gaps in safety, labeling, and dosing that clinicians currently lack oversight for.

Wisconsin Democrats File Bill to Legalize Adult-Use, Medical Cannabis; Regulate Intoxicating Hemp

Wisconsin Democrats propose legislation legalizing adult-use and medical cannabis while regulating intoxicating hemp products, establishing DHS oversight of medical programs.

Rare Cannabinoid Company Expands Mood Collection with New THC-Free CBC Gummies …

# Summary for Cannabis Clinicians This article covers a company’s new THC-free CBC gummies and CBC’s distinct pharmacological mechanisms, relevant to clinicians seeking non-intoxicating cannabinoid options with different receptor interactions than CBD or THC.

Maryland Senate Delays Vote on Bill Allowing Firefighters to Use Medical Cannabis Off-Duty

Maryland legislators are considering protecting off-duty medical cannabis use by firefighters and first responders to address work-related conditions like chronic pain, PTSD, and sleep disorders.

Upper Township unanimous for weed zone, overriding complaints from residents

# Summary Upper Township unanimously approved a cannabis retail zone despite resident opposition, establishing a local regulatory framework that clinicians should monitor for patient access and product availability changes.

Medical cannabis delivery app seeing growth in the DMV and Jamaica | DC News Now

# Medical Cannabis Delivery Services Medical cannabis delivery apps expand patient access to medicine for individuals with mobility limitations or chronic conditions, improving treatment adherence and equity.

Cannabis industry launches organization to further US policy changes with members from …

# Cannabis Industry Coalition Formation Cannabis industry leaders formed a cross-border organization to influence US federal rescheduling policy during a period of regulatory uncertainty affecting patients and producers.

The Best CBD for Seniors in 2026: Safe, Lab-Tested, and Easy to Use | stupidDOPE

This article reviews CBD products marketed to seniors for pain, sleep, anxiety, and inflammation management, relevant to clinicians advising older patients on cannabinoid therapeutics.

Indiana lawmakers miss deadline, killing key cannabis bill | News | wthitv.com

Indiana’s missed legislative deadline killed cannabis reform, leaving the state without updated policy while neighboring states expand patient access—directly affecting clinician ability to recommend cannabis therapeutically.

Hemp products had illegal THC amounts, mold, pesticides, and carcinogens, investigation finds

# For Cannabis Clinicians Unregulated hemp products contain mislabeled THC levels and harmful contaminants (mold, pesticides, carcinogens), creating patient safety risks and clinical uncertainty regarding actual cannabinoid dosing.

Many NC candidates support medical marijuana legalization | Raleigh News & Observer

# Cannabis Clinician Summary North Carolina political candidates increasingly support medical marijuana legalization despite the state’s current prohibition, indicating potential future policy change affecting patient access and clinical practice.

Does Weed Make You Harder or Easier to Manipulate? – Herb

Cannabis impairs prefrontal cortex function and executive decision-making, which clinicians should assess when evaluating patient judgment, risk perception, and vulnerability to manipulation.

Aelis Farma’s AEF0117 THC Interaction Trial Withdrawn: What Investors Should Know

# Cannabis Clinician Summary Aelis Farma discontinued a clinical trial of AEF0117, a selective CB1 receptor inhibitor targeting THC-related adverse effects and cannabis use disorder, requiring clinicians to monitor for alternative treatment developments.

Pres. Trump’s Marijuana Executive Mandate Accelerates MMJ International Holdings … – Newswire

# Summary for Cannabis Clinician This article discusses how potential federal cannabis rescheduling through executive action could impact international medical marijuana manufacturers and their regulatory compliance pathways.

Veterans Groups Urge Congress To Expand Psychedelics And Marijuana Access To …

# Veterans Groups Push for VA Cannabis and Psychedelic Access Veterans organizations are advocating for expanded VA access to cannabis and psychedelic therapies to address veteran suicide rates, relevant to clinicians treating this population.

The Fire Station partners with Citizens for a Safe & Clean Lake Superior for cannabis vape …

# Summary The Fire Station collaborates with Citizens for a Safe & Clean Lake Superior on cannabis vape initiatives, addressing product safety and environmental concerns relevant to clinical cannabis practice.

Boulder and CBD: The Entourage Effect Explained | About Boulder County Colorado

# One-Sentence Summary The entourage effect describes how multiple cannabis plant compounds together produce therapeutic benefits that isolated cannabinoids cannot achieve alone—clinically relevant for treatment optimization.

Indiana S.B. 250 could close Lafayette hemp-beverage sales without a key amendment

Indiana S.B. 250 could ban legal hemp-derived cannabinoid beverages, affecting patients currently using these regulated products for symptom management without specified amendments.

The Best CBD for Immune Support and Daily Resilience in 2026 | stupidDOPE | Est. 2008

# Summary for Cannabis Clinician This article reviews CBD’s mechanisms in the endocannabinoid system for immune and stress regulation, relevant to clinicians evaluating cannabinoid-based therapeutic applications.

Louisiana Lawmakers Advance Adult-Use Cannabis Pilot Bill – KQKI News

Louisiana is developing an adult-use cannabis pilot program to generate regulatory and public health data, which clinicians need to understand evolving legal frameworks affecting patient access and clinical practice.

As Congress debates hemp-derived THC ban, Pa. lawmakers look for other options

# Summary for Cannabis Clinician Pennsylvania lawmakers are developing regulatory frameworks for hemp-derived THC products, which currently operate in a legal gray zone affecting patient access and product safety standards.

West Virginia House approves bill allowing medical cannabis edibles | WV News

West Virginia’s House approved medical cannabis edibles, expanding treatment options for patients who cannot use inhalable forms due to respiratory conditions.

The Wait is Over: Medical Cannabis set to roll out in April | WHNT.com

Alabama’s medical cannabis program launching in April represents regulatory expansion for clinicians to treat qualifying conditions including chronic pain, PTSD, and anxiety.

Branford industrial site sold, to become cannabis growing operation – New Haven Register

# One Sentence Summary An industrial site in Branford was sold and will be converted into a cannabis growing operation, representing commercial cultivation expansion in Connecticut.

Utah Lawmakers Pass Bill To Support Clinical Trials On Psychedelics For Veterans’ Mental Health

# Summary: Utah lawmakers approved legislation enabling clinical trials of psychedelics for treating veterans’ mental health conditions, expanding research opportunities beyond cannabis into alternative therapeutic compounds.

The Best CBD for Mental Clarity and Focus in 2026 | stupidDOPE | Est. 2008

This article examines CBD’s mechanisms of action on multiple receptor systems and their potential therapeutic applications for cognitive and mental health outcomes in clinical cannabis practice.

Study uncovers another reason not to skimp on sleep – ASU News

Sleep deprivation impairs prefrontal cortex function, increasing impulsive decision-making and substance use risk—clinicians should assess sleep quality when evaluating cannabis use patterns and relapse vulnerability.

OCM issues precautionary recall for select cannabis products tested by Keystone Lab – CBS 6 Albany

# Cannabis Recall Summary The New York State Office of Cannabis Management recalled cannabis products from Keystone Lab due to testing integrity concerns, affecting product safety verification for clinical use.

High Tide joins U.S. National Compassionate Care Council | HITI Stock News

High Tide’s participation in the U.S. National Compassionate Care Council addresses standardizing medical cannabis access policies, enabling clinicians to provide consistent, evidence-based patient care across regulatory jurisdictions.

Oklahoma Seeks to Backtrack on Medical Marijuana as Pitfalls Multiply

Oklahoma’s permissive medical cannabis regulations led to oversaturation, diversion risks, and quality control issues, prompting rollback efforts—important for clinicians to understand evolving regulatory landscapes affecting patient access and product safety.

SA risks missing R40bn hemp industry opportunity without coherent strategy – Business Day

South Africa’s fragmented hemp regulatory framework threatens a R40 billion industry opportunity that could supply CBD and industrial materials, requiring coordinated national strategy for clinical and commercial viability.

Kearney man charged with selling THC cartridges to undercover officer near school – Nebraska TV

# Summary A Kearney, Nebraska man faced charges for selling THC cartridges to an undercover officer near a school, highlighting law enforcement focus on illicit cannabis distribution in sensitive locations.

The Office Is Issuing A Recall On Multiple Adult-Use Cannabis Products Tested By Keystone …

# Cannabis Product Recalls Due to Testing Issues Regulated cannabis product recalls occur when testing labs detect contaminants or labeling inaccuracies, requiring clinicians to verify patient product safety and efficacy.

Linnea Achieves CEP Certification for Cannabidiol Isolate – Morningstar

# CEP Certification for Cannabidiol Isolate Linnea’s cannabidiol isolate achieved European Pharmacopoeia certification, ensuring consistent purity and manufacturing standards—critical for clinicians requiring pharmaceutical-grade CBD with documented safety and quality assurance.

Substance use on the rise among Gen Z in their early 20s – Medical Xpress

# Summary This article reports increasing substance use patterns among Gen Z young adults, relevant to clinicians for understanding epidemiological trends in their patient population’s demographics and risk profiles.

Senate Bill would repeal 24% wholesale tax on marijuana – WTVB

# Cannabis Clinician Summary A proposed Senate bill seeks to eliminate a 24% wholesale marijuana tax implemented January 2026, which industry advocates claim creates excessive financial burden on cannabis producers.

R40bn opportunity for hemp industrialisation in South Africa requires policy support – LSF study

This study quantifies South Africa’s R40 billion hemp industrialization potential, relevant to clinicians as policy development directly affects cannabis medicine availability, supply chains, and regulatory pathways for therapeutic access.

Bill to require stricter packaging requirements for marijuana edibles dies in Oregon legislature

Oregon’s failed packaging bill would have mandated individual wrapping and standardized dosing for edibles, addressing accidental ingestion risks—a clinical concern for clinicians counseling patients on safe storage and dosing.

Germany’s Medical Cannabis Boom: Data-Driven Insights for Investors | INN

# One Sentence Summary Germany’s medical cannabis market growth is tracked through patient data analysis, providing clinicians with real-world evidence on therapeutic effectiveness and treatment outcomes.

New study reveals how many Americans use CBD — and why | GreenState

# CBD Usage Epidemiology This study documents CBD use prevalence and patterns across diverse American demographics, providing clinicians with epidemiological data on patient populations and therapeutic applications.

New Report: Poland Medical Cannabis Market Data Shows Full Post-Ban Recovery

Poland’s medical cannabis market recovery demonstrates regulatory progress in European medical cannabis access, relevant for clinicians tracking international policy trends affecting treatment options and patient care standards.

Wisconsin Democrats Introduce Cannabis Legalization Bill – Law360 Tax Authority

Wisconsin Democrats introduced recreational cannabis legalization legislation with regulatory and taxation frameworks, relevant to clinicians managing patient access and understanding evolving state legal landscapes.

CBD oil restores quality of life for sisters, sharing concerns about new regulations with hemp …

Two sisters report quality-of-life improvements with full-spectrum CBD containing THCA, raising clinical considerations about THCA efficacy and regulatory impacts on hemp-derived cannabinoid access.

ACLU previews cannabis & guns arguments for Supreme Court (Newsletter: February 26, 2026)

# Summary for Cannabis Clinicians This case examines whether federal cannabis prohibition can deny gun rights to state-legal cannabis users, affecting clinical documentation and patient counseling regarding legal consequences of cannabis use.

Texas Voters Disapprove Of How State Officials Are Handling Marijuana And THC Laws, Poll Shows

# Cannabis Clinician Context Texas voters disapprove of state marijuana/THC policy management, reflecting regulatory inconsistencies affecting hemp-derived THC products—relevant to clinicians navigating evolving legal frameworks for patient care.

Bridging the Gap: Medical Cannabis, Regulators, and the Reality of Clinical Accountability

# Summary Sentence This article examines the lack of standardized outcome tracking and regulatory clarity that prevents cannabis clinicians from systematically documenting patient safety and efficacy data.

March 5 webinar offers parents lessons on drug/alcohol trends – Rice County, MN

# Cannabis Clinician Summary Educational webinar addressing current cannabis use trends among youth and health impacts, relevant for clinicians counseling affected families and understanding community substance use patterns.

Michigan’s Marijuana Tax Experiment Should Be An Urgent Warning To Other States (Op-Ed)

Michigan’s high cannabis taxes are driving consumers to illicit markets, reducing legal market viability—relevant to clinicians tracking patient access to regulated, tested products.

Curaleaf Earnings: International Growth Offsets Domestic Decline from Continued Price Compression

Curaleaf’s earnings show U.S. cannabis prices declining due to illicit competition and unregulated hemp products, affecting legal market profitability and potentially impacting product availability and pricing for patients.

Kentucky bill would expand cannabis drink sales beyond liquor stores – WKYT

# Cannabis Clinician Summary Kentucky’s SB 223 expands cannabis beverage distribution channels beyond liquor stores, requiring clinicians to understand broader patient access points and potential dosing/consumption patterns.

Advanced drug testing improves patient care at MUSC

MUSC’s advanced drug testing detects THC exposure more accurately and affordably than traditional methods, enabling clinicians to better assess patient cannabis use for informed treatment planning.

As lawmakers in Richmond continue debating a path forward for retail marijuana sales …

Virginia lawmakers debate retail marijuana sales regulations while acknowledging insufficient state-specific scientific evidence on cannabis health and social impacts, complicating evidence-based clinical practice guidelines.

Europe’s Medical Cannabis Market Surges Toward $13 Billion: Last Week in Weed Feb. 23 …

Europe’s medical cannabis market expansion toward $13 billion reflects growing regulatory acceptance, directly impacting clinician access to regulated products and treatment options for patients.

Facing Hemp Ban, PA Lawmakers Race to Regulate THC Drinks and Products

Pennsylvania is developing regulations for THC-infused beverages and hemp products amid federal enforcement, creating implications for clinical practice standards and patient safety monitoring.

Ricketts addresses Congress leaving Nebraska off list protecting state medical cannabis laws

# Summary for Cannabis Clinician Senator Ricketts declined to support Nebraska’s inclusion in federal protections for state medical cannabis laws, creating uncertainty for practitioners operating within state-legal programs.

The Wait is Over: Medical Cannabis set to roll out in April | WKRG.com

Alabama’s medical cannabis program launches in April with dispensary sales, providing clinicians regulatory access to prescribe cannabis products for eligible patients in the state.

From Billion-Dollar Hemp Drinks to FDA Cease-and-Desist Letters: The Cannabis Industry’s …

# Summary for Cannabis Clinicians The FDA is escalating enforcement against cannabis beverage companies making unsubstantiated health claims, creating regulatory uncertainty that affects clinical practice and patient information accuracy.

Popular Diabetes Drugs May Help Combat Multiple Addictions, Major Study Shows

# Summary GLP-1 receptor agonists (diabetes medications) may reduce addiction across multiple substances, offering potential therapeutic options for patients with co-occurring addiction disorders.

The digest reflects a growing body of research on cannabinoid efficacy for metabolic and pain-related conditions, particularly regarding CBD and CBG in liver disease management and anxiety reduction. Regulatory frameworks are actively evolving across multiple jurisdictions, with jurisdictions taking divergent approaches to potency limits and product categories like THC beverages, creating a fragmented landscape for clinical practitioners and patients. This combination of emerging therapeutic evidence and regulatory variability underscores the need for standardized clinical guidance and consistent regulatory oversight to ensure safe, evidence-based cannabinoid use in clinical practice.